Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

1430 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
c-­met-­IN-­1 10mg Inhibitors Other A12488-10

Adooq
10 mg Login
Compare
BCR-­ABL-­IN-­1 1mg Inhibitors Other A12496-1

Adooq
1 mg Login
Compare
BCR-­ABL-­IN-­1 5mg Inhibitors Other A12496-5

Adooq
5 mg Login
Compare
BCR-­ABL-­IN-­1 10mg Inhibitors Other A12496-10

Adooq
10 mg Login
Compare
BCR-­ABL-­IN-­1 50mg Inhibitors Other A12496-50

Adooq
50 mg Login
Compare
PD-­1-­IN-­1 25mg Inhibitors Other A12184-25

Adooq
25 mg Login
Compare
PD-­1-­IN-­1 100mg Inhibitors Other A12184-100

Adooq
100 mg Login
Compare
PD-­1-­IN-­17 100mg Inhibitors Other A12157-100

Adooq
100 mg Login
Compare
PD-­1-­IN-­18 25mg Inhibitors Other A12148-25

Adooq
25 mg Login
Compare
PD-­1-­IN-­18 50mg Inhibitors Other A12148-50

Adooq
50 mg Login
Compare
PD-­1-­IN-­18 100mg Inhibitors Other A12148-100

Adooq
100 mg Login
Compare
PD-­1-­IN-­17 1mg Inhibitors Other A12157-1

Adooq
1 mg Login
Compare
PD-­1-­IN-­1 1mg Inhibitors Other A12184-1

Adooq
1 mg Login
Compare
PD-­1-­IN-­1 5mg Inhibitors Other A12184-5

Adooq
5 mg Login
Compare
PD-­1-­IN-­1 10mg Inhibitors Other A12184-10

Adooq
10 mg Login
Compare
PD-­1-­IN-­1 50mg Inhibitors Other A12184-50

Adooq
50 mg Login
Compare
AB-­MECA 50mg Inhibitors Other A12189-50

Adooq
50 mg Login
Compare
AMG-­Tie2-­1 5mg Download safety datasheet Inhibitors Other A13456-5

Adooq
5 mg Login
Compare
AMG-­Tie2-­1 10mg Download safety datasheet Inhibitors Other A13456-10

Adooq
10 mg Login
Compare
AMG-­Tie2-­1 25mg Download safety datasheet Inhibitors Other A13456-25

Adooq
25 mg Login
Compare
AMG-­Tie2-­1 50mg Download safety datasheet Inhibitors Other A13456-50

Adooq
50 mg Login
Compare
BCH 100mg Inhibitors Other A13370-100

Adooq
100 mg Login
Compare
Napabucasin 10mg Inhibitors Other A13474-10

Adooq
10 mg Login
Compare
Napabucasin 50mg Inhibitors Other A13474-50

Adooq
50 mg Login
Compare
Sancycline 5mg Inhibitors Other A13393-5

Adooq
5 mg Login
Compare
Name Price
c-­met-­IN-­1 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
BCR-­ABL-­IN-­1 1mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
BCR-­ABL-­IN-­1 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
BCR-­ABL-­IN-­1 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
BCR-­ABL-­IN-­1 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
PD-­1-­IN-­1 25mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 25 mg
Available
PD-­1-­IN-­1 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
PD-­1-­IN-­17 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
PD-­1-­IN-­18 25mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 25 mg
Available
PD-­1-­IN-­18 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
PD-­1-­IN-­18 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
PD-­1-­IN-­17 1mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
PD-­1-­IN-­1 1mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
PD-­1-­IN-­1 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
PD-­1-­IN-­1 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
PD-­1-­IN-­1 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
AB-­MECA 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
AMG-­Tie2-­1 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
AMG-­Tie2-­1 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
AMG-­Tie2-­1 25mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 25 mg
Available
AMG-­Tie2-­1 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
BCH 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Napabucasin 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
Napabucasin 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
Sancycline 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available

1430 Item(s)

per page